Inzpera Healthsciences Limited, a active public limited company, was established on 22 June 2016 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74999MH2016PLC282701. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹52.00 Cr and a paid-up capital of ₹49.67 Cr.
It upholds a compliant status. Employing 144 professional, Its leadership includes Kanwar Rameshwar Singh Jamwal (Director), Rajesh Ramadurai (Cfo), Collur Visweswaria Natraj (Director). Past directors included Arup Basu, Ashim Mullick, Rajesh Ramadurai. It holds ₹10.00 Cr open charges and no settled loans. Its latest AGM occurred on 24 September 2025, with the balance sheet filed on 31 March 2025. It is based at 215-217, Avior Corporate Park, Nirmal Galaxy Lbs Road, Mulund (W), Mumbai, Maharashtra, 400080.
U74999MH2016PLC282701
282701
22 June 2016
₹52.00 Cr
₹49.67 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Inzpera Healthsciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kanwar Rameshwar Singh Jamwal | Director | 22 Jun 2016 | Current |
| Rajesh Ramadurai | Cfo | 28 Aug 2018 | Current |
| Collur Visweswaria Natraj | Director | 26 Aug 2021 | Current |
| Narasimhan Jay Kaushik | Managing Director | 22 Jun 2016 | Current |
| Adil Ahmad | Director | 24 May 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 24 Jul 2017 | Past |
| Pramod Abcsdd | Director | 01 Apr 2021 | Past |
| Pramod Abcsdd | Additional Director | 08 Dec 2016 | Past |
| Pramod Abcsdd | Director | 23 May 2017 | Past |
| Pramod Abcsdd | Additional Director | 26 Jun 2022 | Past |
| Pramod Abcsdd | Director | 08 Dec 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Inzpera Healthsciences Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 152.14% increase. The company also saw a substantial fall in profitability, with a 52.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Inzpera Healthsciences had a promoter holding of 100.00%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹100,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Dec 2020 | Others | ₹10.00 Cr | Open |
Explore comprehensive loan charge details -
Inzpera Healthsciences has a workforce of 144 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Inzpera Healthsciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inzpera Healthsciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Inzpera Healthsciences Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records. was completed.
Inzpera Healthsciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Others of Rs. 10.00 Cr registered on 03 Dec 2020 with Charge ID 100398689 was modified on 14 Mar 2023. was completed.
Progress on Collur Visweswaria Natraj was appointed as a Director was appointed as a Director on 26 Aug 2021 & has been associated with this company since 4 years 4 months . was documented.
Progress on A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100398689 was registered on 03 Dec 2020. was documented.
Progress on Mitesh Mahendrabhai Shah was appointed as a Company Secretary was appointed as a Company Secretary on 06 Sep 2018 & has been associated with this company since 7 years 4 months . was documented.
The CIN of Inzpera Healthsciences Limited is U74999MH2016PLC282701.
Inzpera Healthsciences Limited is headquartered at 215-217, Avior Corporate Park, Nirmal Galaxy Lbs Road, Mulund (W), Mumbai, Maharashtra, 400080.
Inzpera Healthsciences Limited was incorporated on 22 June 2016.
The current directors of Inzpera Healthsciences Limited are
The primary industry of Inzpera Healthsciences Limited is Trade.
Inzpera Healthsciences Limited is unlisted.
The authorized capital of Inzpera Healthsciences Limited is ₹52.00 Cr, and the paid-up capital is ₹49.67 Cr.
The compliance status of Inzpera Healthsciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX